Last updated on April 2018

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression


Brief description of study

The standard Johns Hopkins' regimen will be used in study subjects, with the use of donor peripheral blood stem cells, rather than marrow. Clinical outcomes will be defined while focusing efforts on immune reconstitution focusing on immune checkpoint regulators after a related haploidentical stem cell transplant.

Clinical Study Identifier: NCT03480360

Contact Investigators or Research Sites near you

Start Over

Research Nurse

Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Lebanon, NH United States
  Connect »